AGBL5
Basic information
Region (hg38): 2:27042364-27070622
Links
Phenotypes
GenCC
Source:
- retinitis pigmentosa 75 (Strong), mode of inheritance: AR
- retinitis pigmentosa (Supportive), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Retinitis pigmentosa 75 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Ophthalmologic | 26355662; 26720455 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (21 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the AGBL5 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 164 | 178 | ||||
missense | 335 | 346 | ||||
nonsense | 11 | 13 | ||||
start loss | 0 | |||||
frameshift | 14 | |||||
inframe indel | 5 | |||||
splice donor/acceptor (+/-2bp) | 11 | |||||
splice region | 10 | 15 | 2 | 27 | ||
non coding | 45 | 55 | ||||
Total | 21 | 10 | 363 | 213 | 15 |
Highest pathogenic variant AF is 0.00000657
Variants in AGBL5
This is a list of pathogenic ClinVar variants found in the AGBL5 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-27052957-C-T | AGBL5-related disorder | Likely benign (Jan 21, 2020) | ||
2-27052968-C-T | Uncertain significance (Apr 21, 2020) | |||
2-27052976-G-T | Likely benign (Sep 27, 2022) | |||
2-27052977-G-A | Uncertain significance (Jul 12, 2022) | |||
2-27052980-T-C | Likely benign (Oct 17, 2022) | |||
2-27052985-G-A | Likely benign (Jul 19, 2022) | |||
2-27052990-G-A | Inborn genetic diseases | Uncertain significance (Dec 27, 2023) | ||
2-27052993-C-T | Uncertain significance (Oct 02, 2019) | |||
2-27053006-A-G | Likely benign (Jul 19, 2022) | |||
2-27053011-A-G | Uncertain significance (Jun 20, 2022) | |||
2-27053019-C-T | Retinal dystrophy | Uncertain significance (Oct 01, 2023) | ||
2-27053021-C-T | Likely benign (Nov 15, 2023) | |||
2-27053032-T-C | Uncertain significance (Oct 28, 2022) | |||
2-27053036-A-C | Retinal dystrophy | Uncertain significance (Aug 16, 2022) | ||
2-27053043-T-A | Inborn genetic diseases | Uncertain significance (Dec 06, 2024) | ||
2-27053046-A-G | Uncertain significance (Aug 10, 2022) | |||
2-27053047-G-A | Inborn genetic diseases | Uncertain significance (May 03, 2023) | ||
2-27053049-G-C | Retinal dystrophy | Uncertain significance (Jun 20, 2022) | ||
2-27053051-T-A | Retinal dystrophy | Uncertain significance (Oct 01, 2023) | ||
2-27053065-G-C | Uncertain significance (Sep 12, 2022) | |||
2-27053069-T-C | Likely benign (Jan 01, 2024) | |||
2-27053074-C-T | Uncertain significance (Aug 23, 2022) | |||
2-27053075-G-A | Likely benign (Apr 21, 2022) | |||
2-27053091-G-A | Uncertain significance (Nov 08, 2022) | |||
2-27053100-T-TC | Pathogenic (Jul 19, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
AGBL5 | protein_coding | protein_coding | ENST00000360131 | 14 | 28259 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.37e-8 | 1.00 | 125622 | 0 | 126 | 125748 | 0.000501 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.29 | 462 | 547 | 0.844 | 0.0000346 | 5753 |
Missense in Polyphen | 101 | 157.29 | 0.64213 | 1502 | ||
Synonymous | -0.604 | 217 | 206 | 1.05 | 0.0000118 | 1874 |
Loss of Function | 3.23 | 20 | 42.8 | 0.467 | 0.00000290 | 418 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000725 | 0.000719 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.000498 | 0.000489 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.000318 | 0.000273 |
Middle Eastern | 0.000498 | 0.000489 |
South Asian | 0.00196 | 0.00196 |
Other | 0.000652 | 0.000652 |
dbNSFP
Source:
- Function
- FUNCTION: Metallocarboxypeptidase that mediates protein deglutamylation. Specifically catalyzes the deglutamylation of the branching point glutamate side chains generated by post- translational glutamylation in proteins such as tubulins. In contrast, it is not able to act as a long-chain deglutamylase that shortens long polyglutamate chains, a process catalyzed by AGTPBP1/CCP1, AGBL2/CCP2, AGBL3/CCP3, AGBL1/CCP4 and AGBL4/CCP6. Mediates deglutamylation of CGAS, regulating the antiviral activity of CGAS. {ECO:0000250|UniProtKB:Q09M02}.;
- Pathway
- Post-translational protein modification;Metabolism of proteins;Carboxyterminal post-translational modifications of tubulin
(Consensus)
Intolerance Scores
- loftool
- 0.737
- rvis_EVS
- -0.99
- rvis_percentile_EVS
- 8.6
Haploinsufficiency Scores
- pHI
- 0.291
- hipred
- Y
- hipred_score
- 0.515
- ghis
- 0.521
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0761
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Agbl5
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); immune system phenotype;
Zebrafish Information Network
- Gene name
- agbl5
- Affected structure
- ventricular system
- Phenotype tag
- abnormal
- Phenotype quality
- edematous
Gene ontology
- Biological process
- proteolysis;protein deglutamylation;protein branching point deglutamylation;defense response to virus
- Cellular component
- nucleus;cytoplasm;cytosol;microtubule cytoskeleton;midbody;intercellular bridge;mitotic spindle
- Molecular function
- metallocarboxypeptidase activity;zinc ion binding;tubulin binding